Validation of Methods for CYP2C9 Genotyping: Frequencies of Mutant Alleles in a Swedish Population
- 27 January 1999
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 254 (3), 628-631
- https://doi.org/10.1006/bbrc.1998.9992
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Cytochrome P4502C9: an enzyme of major importance in human drug metabolismBritish Journal of Clinical Pharmacology, 1998
- Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2CBiochemical Pharmacology, 1997
- Genetic analysis of the human cytochrome P450 CYP2C9 locusPharmacogenetics, 1996
- The role of the CFP2C9-Leu 359 allelic variant in the tolbutamide polymorphismPharmacogenetics, 1996
- The Substrate Binding Site of Human Liver Cytochrome P450 2C9: An Approach Using Designed Tienilic Acid Derivatives and Molecular ModelingBiochemistry, 1995
- Role of cytochrome P450 2C9 and an allelic variant in the 4′-hydroxylation of (R)- and (S)-flurbiprofenBiochemical Pharmacology, 1995
- Biochemistry and molecular biology of the human CYP2C subfamilyPharmacogenetics, 1994
- Site-directed mutation studies of human liver cytochrome P-450 isoenzymes in the CYP2C subfamilyBiochemical Journal, 1993
- Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactionsChemical Research in Toxicology, 1992
- Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9Biochemical and Biophysical Research Communications, 1991